LacriJet® | 1st Preloaded & Self-Retaining Monocanalicular Nasolacrimal Intubation | Features

LacriJet® is FCI latest and exclusive preloaded & self-retaining monocanalicular nasolacrimal intubation indicated for epiphora, congenital nasolacrimal duct obstruction and canalicular laceration. LacriJet® consists of a single use injector handpiece into which a silicone tube is preloaded inside a metallic guide. Its special design enables to reduce operating time, either in the intubation phase as well as for the removal of the device.

Learn more at: 🌐 https://www.fciworldwide.com/products/lacrijet/

Follow us on LinkedIn: 🖥️ https://www.linkedin.com/company/fci-...

Veröffentlicht am 20.01.2025

Alle FCI SAS videos

TAGS